Cirqle Biomedical Holding ApS: Financial statements 2021
CVR: 39849585
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Cirqle Biomedical Holding ApS (CVR 39849585) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -6,729 and a net result of DKK -11,725 compared with DKK -10,281 the year before. Equity in the 2021 report amounted to DKK 25,496. The solvency ratio was 16.5%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -6,729
- Profit/Loss
- DKK -11,725
- Equity
- DKK 25,496
- Total Assets
- DKK 154,169
- Employees
- 1
Official annual report
Find more companies like Cirqle Biomedical Holding ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
Cirqle Biomedical Holding ApS has published its annual report for 2020. Gross profit came to DKK -7,329, and the net result was DKK -10,281.
About Cirqle Biomedical Holding ApS
Cirqle Biomedical Holding ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2018. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named Circle Biomedical Holding ApS and Circle Biomedical Holding IVS. The management consists of Frederik Petursson Madsen and Thomas Crouzier. The company is owned by FREDERIK MADSEN HOLDING ApS and Seatoo Holding ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -60,937 and a net result of DKK -137,510 compared with DKK 12,948,727 the year before. Equity in the 2025 report amounted to DKK 577,835.